Early day motion tabled by primary sponsor Sharon Hodgson (Labour), on Tuesday, 13 July 2010, in the House of Commons. It is signed by 43 members in total.

---

TREATMENT FOR KIDNEY CANCER

That this House observes that between 7,000 and 8,000 people are diagnosed with kidney cancer in the UK each year, and that around 40 per cent. of patients have advanced cancer at the time of diagnosis; notes that everolimus is the only licensed treatment for patients with advanced and/or metastatic renal cell carcinoma who have failed on first-line treatment; notes with concern that the National Institute for Health and Clinical Excellence (NICE) has not recommended funding for everolimus; is concerned by the number of clinically effective cancer drugs which are turned down by NICE despite additional guidance on end-of-life medicines issued by NICE to the appraisal committees; and calls on NICE to reconsider its recommendations so that patients may be able to access this drug on the NHS.

---

Secondary information

Type

Early day motion

Reference

491 

Session

2010-12

Other sponsors

Catherine McKinnell

Russell Brown

David Anderson

Roberta Blackman-Woods

Sian C James

Subjects

Health services Diseases

Link

View this Early day motion on www.parliament.uk